Presentation of NAION in a Global Treatment Trial

Update item information
Identifier 20190318_nanos_sciplatform1_04
Title Presentation of NAION in a Global Treatment Trial
Creator Mark J. Kupersmith, MD
Subject Optic Neuropathy, Vascular Disorders, Visual Fields
Description Knowledge of presenting features and systemic factors associated with acute NAION is based predominantly on retrospective reports and one prospective treatment trial, with only 258 participants. The Quark / NORDIC NAION treatment trial will recruit 800 participants and the features of the first 400 enrolled provides the largest prospectively uniformly collected dataset on NAION from multiple sites in 8 countries.
Relation is Part of NANOS Annual Meeting 2019: Scientific Platform Presentations (Session 1)
Contributor Primary Mark J. Kupersmith, MD
Contributor Secondary Neil Miller, Mays El-Dairi, Leonard Levin, Sharon Klier
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Date 2019-03
Format video/mp4
Source 2019 North American Neuro-Ophthalmology Society Annual Meeting
Rights Management Copyright 2019. For further information regarding the rights to this collection, please visit:
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Collection Neuro-ophthalmology Virtual Education Library: NOVEL
Language eng
ARK ark:/87278/s6mh24q3
Setname ehsl_novel_nam
Date Created 2019-05-08
Date Modified 2019-05-08
ID 1426137
Reference URL
Back to Search Results